Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
Britannia Q1 Results : Cons PAT rises 3% YoY to Rs 521 crore, revenue grows 9%
5/08/2025
BLS International reports revenues of Rs 711 cr for Q1FY26M PAT at Rs 181 crore
5/08/2025
Bonus Alert : After five free shares in 2024, metal stock to consider another proposal on August 8
5/08/2025
These 11 smallcap stocks with 25%+ RoE surge up to 50% in FY26 so far
5/08/2025
BSE SME exchange crosses 600 listings milestone, cos raise Rs 10,652 crore
5/08/2025
2 top stock recommendations from Dharmesh Shah
5/08/2025
